))
The Big Picture - Discussing Clinical Entry to Commercial Planning in Radiotherapy With Ben Pais, SVP Aricieum
Manage episode 415313823 series 3557116
Content provided by Charles Spence. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Charles Spence or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, Ben Pais, Senior Vice President at Ariceum Therapeutics, discusses innovative cancer treatments. His company develops drugs that use radiation to combat cancer.
He explains their strategies and adjustments in medical technology, focusing on radiotherapy.
He talks about the challenges of producing and distributing these drugs and the importance of having capable leaders.
Ben also explores future developments in this field and how large pharmaceutical companies acquiring smaller ones can impact the industry.
Here's what you are in for:
00:22 Moving from Clinical Medicine to Pharma
02:00 Starting Out from Surgery to Pharma
04:33 Discovering New Areas in Pharma
08:50 Getting into Radiopharmaceuticals
16:02 Growing in a Radiopharmaceutical Career
19:25 Understanding Radiopharmaceuticals: Simple to Complex
24:34 Finding Your Way in the Radiopharmaceutical Field
33:57 What's Next for Radiopharmaceuticals and Career Tips
About Ben Pais
Ben is a doctor with 25 years in the life science field. He knows about urology, cardiology, and radiation oncology. He has handled clinical trials (phase I-IV), medical affairs, drug safety, getting products to market, launching products, and early sales steps. Since 2019, he's been a certified Pharmaceutical Physician NVFG. In 2020, he started at Ipsen as the Global Development Lead for Radiopharmaceuticals. Later, he moved to Ariceum.
About Charles
Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.
He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.
In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.
Connect with Charles:
LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/
Website: https://www.discera-search.com/
16 episodes
Share
